NetraMark Holdings Inc. announced that Dr. Larry Alphs has joined the NetraMark Advisory Board. As part of the continued efforts to commercialize the NetraMark AI based offerings, the Company is reconstituting its Advisory Board with key pharmaceutical industry leaders. Dr. Larry Alphs comes with a deep history in the pharmaceutical industry having formerly served as Executive Director at Pfizer, as the former Therapeutic Area Leader, Psychiatry at Johnson & Johnson and currently Sr. VP CNS Development at Denovo Biopharma.Dr. Alphs will play an active role in supporting the management team of NetraMark as it evaluates strategic growth and scientific initiatives.